Health Trials

Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis

1

Review clinical trials related to Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase III Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of Plonmarlimab in Subjects With Relapsed/Refractory Rheumatic and Immunologic Disease-associated Haemophagocytic Lymphohistiocytosis (Also Known as Macrophage Activation Syndrome [MAS])

A study designed to evaluate the efficacy, safety, immunogenicity, PK, and PD characteristics of Plonmarlimab in patients with relapsed/refractory rheumatic and immunologic disease-associated MAS, and to explore biomarkers related to the efficacy of Plonmarlimab.

Participants needed: 30
Trial details
Phase: Phase 3Age: 16-80Biological sex: AllType: InterventionalSponsor: TJ Biopharma Co., Ltd.Updated: Jun 24, 2026Locations: 15
Eligibility criteria

Age: 16 to 80 years (inclusive), of any gender. [+4]

Confirmed or suspected primary haemophagocytic lymphohistiocytosis (pHLH). [+16]

Read more